help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by SEEMUNGAL, T. A. R.
Right arrow Articles by WEDZICHA, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by SEEMUNGAL, T. A. R.
Right arrow Articles by WEDZICHA, J. A.

Am. J. Respir. Crit. Care Med., Volume 157, Number 5, May 1998, 1418-1422

Effect of Exacerbation on Quality of Life in Patients with Chronic Obstructive Pulmonary Disease

TERENCE A. R. SEEMUNGAL, GAVIN C. DONALDSON, ELIZABETH A. PAUL, JANINE C. BESTALL, DONALD J. JEFFRIES, and JADWIGA A. WEDZICHA

Academic Departments of Respiratory Medicine, Physiology, Environmental and Preventive Medicine, and Virology, St. Bartholomew's and Royal London School of Medicine and Dentistry, London, United Kingdom

Exacerbations occur commonly in patients with moderate or severe chronic obstructive pulmonary disease (COPD) but factors affecting their severity and frequency or effects on quality of life are unknown. We measured daily peak expiratory flow rate (PEFR) and daily respiratory symptoms for 1 yr in 70 COPD patients (52 male, 18 female, mean age [± SD] 67.5 ± 8.3 yr, FEV1 1.06 ± 0.45 L, FVC 2.48 ± 0.82 L, FEV1/FVC 44 ± 15%, FEV1 reversibility 6.7 ± 9.1%, PaO2 8.8 ± 1.1 kPa). Quality of life was measured by the St. George's Respiratory Questionnaire (SGRQ). Exacerbations (E) were assessed at acute visit (reported exacerbation) or from diary card data each month (unreported exacerbation). In 61 (87%) patients there were 190 exacerbations (median 3; range, 1 to 8) of which 93 (51%) were reported. There were no differences in major symptoms (increase in dyspnea, sputum volume, or purulence) or physiological parameters between reported and unreported exacerbations. At exacerbation, median peak flow fell by an average of 6.6 L/min (p = 0.0003). Using the median number of exacerbations as the cutoff point, patients were classified as infrequent exacerbators (E = 0 to 2) or frequent exacerbators (E = 3 to 8). The SGRQ Total and component scores were significantly worse in the group that had frequent exacerbations: SGRQ Total score (mean difference = 14.8, p < 0.001), Symptoms (23.1, p < 0.001), Activities (12.2, p = 0.003), Impacts (13.9, p = 0.002). However there was no difference between frequent and infrequent exacerbators in the fall in peak flow at exacerbation. Factors predictive of frequent exacerbations were daily cough (p = 0.018), daily wheeze (p = 0.011), and daily cough and sputum (p = 0.009) and frequent exacerbations in the previous year (p = 0.001). These findings suggest that patient quality of life is related to COPD exacerbation frequency.




This article has been cited by other articles:


Home page
 ANN INTERN MEDHome page
D. E. Niewoehner, K. Rice, C. Cote, D. Paulson, J. A. D. Cooper Jr., L. Korducki, C. Cassino, and S. Kesten
Prevention of Exacerbations of Chronic Obstructive Pulmonary Disease with Tiotropium, a Once-Daily Inhaled Anticholinergic Bronchodilator: A Randomized Trial
Ann Intern Med, September 6, 2005; 143(5): 317 - 326.
[Abstract] [Full Text] [PDF]

Home page
 ANN INTERN MEDHome page
G. M. Turino
Therapeutic Gains of Prolonged Bronchial Dilatation in Chronic Obstructive Pulmonary Disease
Ann Intern Med, September 6, 2005; 143(5): 386 - 387.
[Full Text] [PDF]

Home page
 NEJMHome page
E. Garcia-Pachon, I. Padilla-Nava, S. S. Kostianev, D. H. Iluchev, V. Sankaranarayanan, T. Ziedalski, M. K. Gould, P. Ussetti, R. Laporta, and B. R. Celli
Predicting Outcomes in Chronic Obstructive Pulmonary Disease
N. Engl. J. Med., May 27, 2004; 350(22): 2308 - 2310.
[Full Text] [PDF]

Home page
 NEJMHome page
A. J. Busti, M. D. Vervan, S. D. Brouse, J. R. Hurst, G. C. Donaldson, J. A. Wedzicha, G. Rolla, C. Bucca, A. Salloum, T. Y. Elbaage, et al.
Prednisone for Chronic Obstructive Pulmonary Disease
N. Engl. J. Med., September 25, 2003; 349(13): 1288 - 1290.
[Full Text] [PDF]

Home page
 NEJMHome page
R. S. Irwin and J. M. Madison
Systemic Corticosteroids for Acute Exacerbations of Chronic Obstructive Pulmonary Disease
N. Engl. J. Med., June 26, 2003; 348(26): 2679 - 2681.
[Full Text] [PDF]

Home page
 ThoraxHome page
M D L Morgan
Preventing hospital admissions for COPD: role of physical activity
Thorax, February 1, 2003; 58(2): 95 - 96.
[Full Text] [PDF]

Home page
 ThoraxHome page
J Garcia-Aymerich, E Farrero, M A Felez, J Izquierdo, R M Marrades, and J M Anto
Risk factors of readmission to hospital for a COPD exacerbation: a prospective study
Thorax, February 1, 2003; 58(2): 100 - 105.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
G Rohde, A Wiethege, I Borg, M Kauth, T T Bauer, A Gillissen, A Bufe, and G Schultze-Werninghaus
Respiratory viruses in exacerbations of chronic obstructive pulmonary disease requiring hospitalisation: a case-control study
Thorax, January 1, 2003; 58(1): 37 - 42.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
A J White, S Gompertz, and R A Stockley
Chronic obstructive pulmonary disease * 6: The aetiology of exacerbations of chronic obstructive pulmonary disease
Thorax, January 1, 2003; 58(1): 73 - 80.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
T A R Seemungal, J A Wedzicha, P K MacCallum, S L Johnston, P A Lambert, F Blasi, L Allegra, S Damato, R Raccanelli, R Cosentini, et al.
Chlamydia pneumoniae and COPD exacerbation
Thorax, December 1, 2002; 57(12): 1087 - 1089.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
P. van der Valk, E. Monninkhof, J. van der Palen, G. Zielhuis, and C. van Herwaarden
Effect of Discontinuation of Inhaled Corticosteroids in Patients with Chronic Obstructive Pulmonary Disease: The COPE Study
Am. J. Respir. Crit. Care Med., November 15, 2002; 166(10): 1358 - 1363.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
L. J. Dowson, P. J. Guest, and R. A. Stockley
The Relationship of Chronic Sputum Expectoration to Physiologic, Radiologic, and Health Status Characteristics in {alpha}1-Antitrypsin Deficiency (PiZ)
Chest, October 1, 2002; 122(4): 1247 - 1255.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
N. R. Anthonisen
Bacteria and Exacerbations of Chronic Obstructive Pulmonary Disease
N. Engl. J. Med., August 15, 2002; 347(7): 526 - 527.
[Full Text] [PDF]

Home page
 ChestHome page
S.-s. Yeh, B. DeGuzman, and T. Kramer
Reversal of COPD-Associated Weight Loss Using the Anabolic Agent Oxandrolone*
Chest, August 1, 2002; 122(2): 421 - 428.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
V. S. Fan, J. R. Curtis, S.-P. Tu, M. B. McDonell, and S. D. Fihn
Using Quality of Life to Predict Hospitalization and Mortality in Patients With Obstructive Lung Diseases*
Chest, August 1, 2002; 122(2): 429 - 436.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
R. A. Stockley
Neutrophils and the Pathogenesis of COPD*
Chest, May 1, 2002; 121(5_suppl): 151S - 155S.
[Full Text] [PDF]

Home page
 NEJMHome page
J. K. Stoller
Acute Exacerbations of Chronic Obstructive Pulmonary Disease
N. Engl. J. Med., March 28, 2002; 346(13): 988 - 994.
[Full Text] [PDF]

Home page
 ChestHome page
S. D. Aaron, K. L. Vandemheen, J. J. Clinch, J. Ahuja, R. J. Brison, G. Dickinson, and P. C. Hebert
Measurement of Short-term Changes in Dyspnea and Disease-Specific Quality of Life Following an Acute COPD Exacerbation
Chest, March 1, 2002; 121(3): 688 - 696.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
C M Roberts, D Lowe, C E Bucknall, I Ryland, Y Kelly, and M G Pearson
Clinical audit indicators of outcome following admission to hospital with acute exacerbation of chronic obstructive pulmonary disease
Thorax, February 1, 2002; 57(2): 137 - 141.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
J. A. Wedzicha
Airway Infection Accelerates Decline of Lung Function in Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., November 15, 2001; 164(10): 1757 - 1758.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
REBUTTAL FROM DR. WEDZICHA
Am. J. Respir. Crit. Care Med., November 15, 2001; 164(10): 1760 - 1760.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
T. SEEMUNGAL, R. HARPER-OWEN, A. BHOWMIK, I. MORIC, G. SANDERSON, S. MESSAGE, P. MACCALLUM, T. W. MEADE, D. J. JEFFRIES, S. L. JOHNSTON, et al.
Respiratory Viruses, Symptoms, and Inflammatory Markers in Acute Exacerbations and Stable Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., November 1, 2001; 164(9): 1618 - 1623.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
P W Jones
Health status measurement in chronic obstructive pulmonary disease
Thorax, November 1, 2001; 56(11): 880 - 887.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
J. GARCIA-AYMERICH, E. MONSO, R. M. MARRADES, J. ESCARRABILL, M. A. FELEZ, J. SUNYER, J. M. ANTO, and the EFRAM Investigators
Risk Factors for Hospitalization for a Chronic Obstructive Pulmonary Disease Exacerbation . EFRAM STUDY
Am. J. Respir. Crit. Care Med., September 15, 2001; 164(6): 1002 - 1007.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
R. E. KANNER, N. R. ANTHONISEN, and J. E. CONNETT
Lower Respiratory Illnesses Promote FEV1 Decline in Current Smokers But Not Ex-Smokers with Mild Chronic Obstructive Pulmonary Disease . Results from the Lung Health Study
Am. J. Respir. Crit. Care Med., August 1, 2001; 164(3): 358 - 364.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
K. Foglio, L. Bianchi, and N. Ambrosino
Is It Really Useful To Repeat Outpatient Pulmonary Rehabilitation Programs in Patients With Chronic Airway Obstruction? : A 2-Year Controlled Study
Chest, June 1, 2001; 119(6): 1696 - 1704.
[Abstract] [Full Text] [PDF]

Home page
 BMJHome page
P. J Poole and P. N Black

BMJ, May 26, 2001; 322(7297): 1271 - 1271.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
B. J. Lipworth, C. M. Jackson, A. De Maria, G. W. Canonica, D. W. Reid, A. Soltani, H. Walters, S. O'Connor, R. Wise, J. Connett, et al.
Inhaled Triamcinolone and Chronic Obstructive Pulmonary Disease
N. Engl. J. Med., May 17, 2001; 344(20): 1553 - 1556.
[Full Text] [PDF]

Home page
 ChestHome page
D. C. McCrory, C. Brown, S. E. Gelfand, and P. B. Bach
Management of Acute Exacerbations of COPD : A Summary and Appraisal of Published Evidence
Chest, April 1, 2001; 119(4): 1190 - 1209.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
S. SPENCER, P. M. A. CALVERLEY, P. SHERWOOD BURGE, and P. W. JONES
Health Status Deterioration in Patients with Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., January 1, 2001; 163(1): 122 - 128.
[Abstract] [Full Text]

Home page
 ThoraxHome page
M Roland, A Bhowmik, R J Sapsford, T A R Seemungal, D J Jeffries, T D Warner, and J A Wedzicha
Sputum and plasma endothelin-1 levels in exacerbations of chronic obstructive pulmonary disease
Thorax, January 1, 2001; 56(1): 30 - 35.
[Abstract] [Full Text]

Home page
 ThoraxHome page
S Gompertz, D L Bayley, S L Hill, and R A Stockley
Relationship between airway inflammation and the frequency of exacerbations in patients with smoking related COPD
Thorax, January 1, 2001; 56(1): 36 - 41.
[Abstract] [Full Text]

Home page
 ChestHome page
V. Leyenson, S. Furukawa, A. M. Kuzma, F. Cordova, J. Travaline, and G. J. Criner
Correlation of Changes in Quality of Life After Lung Volume Reduction Surgery With Changes in Lung Function, Exercise, and Gas Exchange
Chest, September 1, 2000; 118(3): 728 - 735.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
J A WEDZICHA
The heterogeneity of chronic obstructive pulmonary disease
Thorax, August 1, 2000; 55(8): 631 - 632.
[Full Text]

Home page
 NEJMHome page
P. J. Barnes
Chronic Obstructive Pulmonary Disease
N. Engl. J. Med., July 27, 2000; 343(4): 269 - 280.
[Full Text] [PDF]

Home page
 BMJHome page
P S Burge, P M A Calverley, P W Jones, S Spencer, J A Anderson, and T K Maslen
Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial
BMJ, May 13, 2000; 320(7245): 1297 - 1303.
[Abstract] [Full Text]

Home page
 Am. J. Respir. Crit. Care Med.Home page
T. A. R. SEEMUNGAL, G. C. DONALDSON, A. BHOWMIK, D. J. JEFFRIES, and J. A. WEDZICHA
Time Course and Recovery of Exacerbations in Patients with Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., May 1, 2000; 161(5): 1608 - 1613.
[Abstract] [Full Text]

Home page
 ChestHome page
S. Sethi
Infectious Etiology of Acute Exacerbations of Chronic Bronchitis
Chest, May 1, 2000; 117(5_suppl_2): 380S - 385S.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
R. Rodriguez-Roisin
Toward a Consensus Definition for COPD Exacerbations
Chest, May 1, 2000; 117(5_suppl_2): 398S - 401S.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
P. M.A. CALVERLEY
Inhaled Corticosteroids Are Beneficial in Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., February 1, 2000; 161(2): 341 - 342.
[Full Text]

Home page
 ThoraxHome page
A. Bhowmik, T. A R Seemungal, R. J Sapsford, and J. A Wedzicha
Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations
Thorax, February 1, 2000; 55(2): 114 - 120.
[Abstract] [Full Text]

Home page
 Am. J. Respir. Crit. Care Med.Home page
N. MOGULKOC, S. KARAKURT, B. ISALSKA, U. BAYINDIR, T. ÇELIKEL, V. KORTEN, and N. ÇOLPAN
Acute Purulent Exacerbation of Chronic Obstructive Pulmonary Disease and Chlamydia pneumoniae Infection
Am. J. Respir. Crit. Care Med., July 1, 1999; 160(1): 349 - 353.
[Abstract] [Full Text]

Home page
 ThoraxHome page
A Bhowmik, T A R Seemungal, R J Sapsford, J L Devalia, and J A Wedzicha
Comparison of spontaneous and induced sputum for investigation of airway inflammation in chronic obstructive pulmonary disease
Thorax, November 1, 1998; 53(11): 953 - 956.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 1998 American Thoracic Society 		  ATS State of the Art 2009